Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiolo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 2021-11, Vol.520, p.1-11
Hauptverfasser: Cai, Jie, Chen, Hongda, Lu, Ming, Zhang, Yuhan, Lu, Bin, You, Lei, Zhang, Taiping, Dai, Min, Zhao, Yupei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11
container_issue
container_start_page 1
container_title Cancer letters
container_volume 520
creator Cai, Jie
Chen, Hongda
Lu, Ming
Zhang, Yuhan
Lu, Bin
You, Lei
Zhang, Taiping
Dai, Min
Zhao, Yupei
description Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiology of pancreatic cancer, including its epidemiological trends, risk factors, risk prediction models, screening modalities, and prognosis. The risk factors for pancreatic cancers can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. Several prediction models for pancreatic cancer have been developed in populations with new-onset diabetes or a family history of pancreatic cancer; however, these models require further validation. Despite recent progress in pancreatic cancer screening, the quantity and quality of related studies are also unsatisfactory, especially with respect to the identification of high-risk populations and development of effective screening modality. Apart from the populations with familial genetic risk and those at a high risk of sporadic pancreatic cancer, risk factors such as new-onset diabetes may be a new direction for timely intervention. We hope this work will provide new ideas for further prevention and treatment of pancreatic cancer. •Both incidence and mortality rate of pancreatic cancer has increased in recent years.•Risk factors for PDAC include individual characteristics, lifestyle and environment, and disease status.•The current established modality for effective early detection of PDAC is lacking.•Development of effective biomarkers predicting the prognosis are in high demand.
doi_str_mv 10.1016/j.canlet.2021.06.027
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2548403274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383521003128</els_id><sourcerecordid>2570438080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-ca91794b1c4ad700c8a120729347170441f9d4cd701fb5273359ccf8d9a0196a3</originalsourceid><addsrcrecordid>eNp9kU9rGzEQxUVJaZy036AUQS49ZLejP7vS9hAwIUkLgV7Ss5ClWVfuWnKldSDfvjJOe8ghp2GY38wb3iPkI4OWAeu_bFpn44Rzy4GzFvoWuHpDFkwr3qhBwwlZgADZCC26U3JWygYAOqm6d-RUSM76XusFsUv_aKPDQkOk8y-kuAsetyFNaf1E00h3dZrRzsFRdwDzV_qQMfpySXMov-lo3Zxy7UrFMIa4vqQ2errLaR1TCeU9eTvaqeCH53pOft7ePFx_a-5_3H2_Xt43Tnb93Dg7MDXIFXPSegXgtGUcFB-EVEyBlGwcvHR1xMZVx5UQ3eDcqP1ggQ29Fefk8_FuVf6zxzKbbSgOp8lGTPtieCe1BMGVrOjFC3ST9jnW7ypVtYQGDZWSR8rlVErG0exy2Nr8ZBiYQwRmY44RmEMEBnpTI6hrn56P71db9P-X_nlegasjgNWNx4DZFBewWutDRjcbn8LrCn8BGyGX8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570438080</pqid></control><display><type>article</type><title>Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Cai, Jie ; Chen, Hongda ; Lu, Ming ; Zhang, Yuhan ; Lu, Bin ; You, Lei ; Zhang, Taiping ; Dai, Min ; Zhao, Yupei</creator><creatorcontrib>Cai, Jie ; Chen, Hongda ; Lu, Ming ; Zhang, Yuhan ; Lu, Bin ; You, Lei ; Zhang, Taiping ; Dai, Min ; Zhao, Yupei</creatorcontrib><description>Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiology of pancreatic cancer, including its epidemiological trends, risk factors, risk prediction models, screening modalities, and prognosis. The risk factors for pancreatic cancers can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. Several prediction models for pancreatic cancer have been developed in populations with new-onset diabetes or a family history of pancreatic cancer; however, these models require further validation. Despite recent progress in pancreatic cancer screening, the quantity and quality of related studies are also unsatisfactory, especially with respect to the identification of high-risk populations and development of effective screening modality. Apart from the populations with familial genetic risk and those at a high risk of sporadic pancreatic cancer, risk factors such as new-onset diabetes may be a new direction for timely intervention. We hope this work will provide new ideas for further prevention and treatment of pancreatic cancer. •Both incidence and mortality rate of pancreatic cancer has increased in recent years.•Risk factors for PDAC include individual characteristics, lifestyle and environment, and disease status.•The current established modality for effective early detection of PDAC is lacking.•Development of effective biomarkers predicting the prognosis are in high demand.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2021.06.027</identifier><identifier>PMID: 34216688</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Biomarker ; Cancer screening ; Diabetes mellitus ; Early Detection of Cancer ; Epidemiology ; Gender differences ; Humans ; Literature reviews ; Malignancy ; Mathematical models ; Medical prognosis ; Mortality ; Mutation ; Pancreas - pathology ; Pancreatic cancer ; Pancreatic Neoplasms - diagnosis ; Pancreatic Neoplasms - epidemiology ; Pancreatic Neoplasms - genetics ; Pancreatic Neoplasms - therapy ; Population genetics ; Prediction model ; Prediction models ; Prognosis ; Risk Factors ; Screening ; Systematic review ; Trend</subject><ispartof>Cancer letters, 2021-11, Vol.520, p.1-11</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><rights>2021. Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-ca91794b1c4ad700c8a120729347170441f9d4cd701fb5273359ccf8d9a0196a3</citedby><cites>FETCH-LOGICAL-c456t-ca91794b1c4ad700c8a120729347170441f9d4cd701fb5273359ccf8d9a0196a3</cites><orcidid>0000-0002-2691-0411</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0304383521003128$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34216688$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cai, Jie</creatorcontrib><creatorcontrib>Chen, Hongda</creatorcontrib><creatorcontrib>Lu, Ming</creatorcontrib><creatorcontrib>Zhang, Yuhan</creatorcontrib><creatorcontrib>Lu, Bin</creatorcontrib><creatorcontrib>You, Lei</creatorcontrib><creatorcontrib>Zhang, Taiping</creatorcontrib><creatorcontrib>Dai, Min</creatorcontrib><creatorcontrib>Zhao, Yupei</creatorcontrib><title>Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiology of pancreatic cancer, including its epidemiological trends, risk factors, risk prediction models, screening modalities, and prognosis. The risk factors for pancreatic cancers can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. Several prediction models for pancreatic cancer have been developed in populations with new-onset diabetes or a family history of pancreatic cancer; however, these models require further validation. Despite recent progress in pancreatic cancer screening, the quantity and quality of related studies are also unsatisfactory, especially with respect to the identification of high-risk populations and development of effective screening modality. Apart from the populations with familial genetic risk and those at a high risk of sporadic pancreatic cancer, risk factors such as new-onset diabetes may be a new direction for timely intervention. We hope this work will provide new ideas for further prevention and treatment of pancreatic cancer. •Both incidence and mortality rate of pancreatic cancer has increased in recent years.•Risk factors for PDAC include individual characteristics, lifestyle and environment, and disease status.•The current established modality for effective early detection of PDAC is lacking.•Development of effective biomarkers predicting the prognosis are in high demand.</description><subject>Biomarker</subject><subject>Cancer screening</subject><subject>Diabetes mellitus</subject><subject>Early Detection of Cancer</subject><subject>Epidemiology</subject><subject>Gender differences</subject><subject>Humans</subject><subject>Literature reviews</subject><subject>Malignancy</subject><subject>Mathematical models</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Pancreas - pathology</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - diagnosis</subject><subject>Pancreatic Neoplasms - epidemiology</subject><subject>Pancreatic Neoplasms - genetics</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Population genetics</subject><subject>Prediction model</subject><subject>Prediction models</subject><subject>Prognosis</subject><subject>Risk Factors</subject><subject>Screening</subject><subject>Systematic review</subject><subject>Trend</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9rGzEQxUVJaZy036AUQS49ZLejP7vS9hAwIUkLgV7Ss5ClWVfuWnKldSDfvjJOe8ghp2GY38wb3iPkI4OWAeu_bFpn44Rzy4GzFvoWuHpDFkwr3qhBwwlZgADZCC26U3JWygYAOqm6d-RUSM76XusFsUv_aKPDQkOk8y-kuAsetyFNaf1E00h3dZrRzsFRdwDzV_qQMfpySXMov-lo3Zxy7UrFMIa4vqQ2errLaR1TCeU9eTvaqeCH53pOft7ePFx_a-5_3H2_Xt43Tnb93Dg7MDXIFXPSegXgtGUcFB-EVEyBlGwcvHR1xMZVx5UQ3eDcqP1ggQ29Fefk8_FuVf6zxzKbbSgOp8lGTPtieCe1BMGVrOjFC3ST9jnW7ypVtYQGDZWSR8rlVErG0exy2Nr8ZBiYQwRmY44RmEMEBnpTI6hrn56P71db9P-X_nlegasjgNWNx4DZFBewWutDRjcbn8LrCn8BGyGX8Q</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Cai, Jie</creator><creator>Chen, Hongda</creator><creator>Lu, Ming</creator><creator>Zhang, Yuhan</creator><creator>Lu, Bin</creator><creator>You, Lei</creator><creator>Zhang, Taiping</creator><creator>Dai, Min</creator><creator>Zhao, Yupei</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2691-0411</orcidid></search><sort><creationdate>20211101</creationdate><title>Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis</title><author>Cai, Jie ; Chen, Hongda ; Lu, Ming ; Zhang, Yuhan ; Lu, Bin ; You, Lei ; Zhang, Taiping ; Dai, Min ; Zhao, Yupei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-ca91794b1c4ad700c8a120729347170441f9d4cd701fb5273359ccf8d9a0196a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biomarker</topic><topic>Cancer screening</topic><topic>Diabetes mellitus</topic><topic>Early Detection of Cancer</topic><topic>Epidemiology</topic><topic>Gender differences</topic><topic>Humans</topic><topic>Literature reviews</topic><topic>Malignancy</topic><topic>Mathematical models</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Pancreas - pathology</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - diagnosis</topic><topic>Pancreatic Neoplasms - epidemiology</topic><topic>Pancreatic Neoplasms - genetics</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Population genetics</topic><topic>Prediction model</topic><topic>Prediction models</topic><topic>Prognosis</topic><topic>Risk Factors</topic><topic>Screening</topic><topic>Systematic review</topic><topic>Trend</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Jie</creatorcontrib><creatorcontrib>Chen, Hongda</creatorcontrib><creatorcontrib>Lu, Ming</creatorcontrib><creatorcontrib>Zhang, Yuhan</creatorcontrib><creatorcontrib>Lu, Bin</creatorcontrib><creatorcontrib>You, Lei</creatorcontrib><creatorcontrib>Zhang, Taiping</creatorcontrib><creatorcontrib>Dai, Min</creatorcontrib><creatorcontrib>Zhao, Yupei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Jie</au><au>Chen, Hongda</au><au>Lu, Ming</au><au>Zhang, Yuhan</au><au>Lu, Bin</au><au>You, Lei</au><au>Zhang, Taiping</au><au>Dai, Min</au><au>Zhao, Yupei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2021-11-01</date><risdate>2021</risdate><volume>520</volume><spage>1</spage><epage>11</epage><pages>1-11</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiology of pancreatic cancer, including its epidemiological trends, risk factors, risk prediction models, screening modalities, and prognosis. The risk factors for pancreatic cancers can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. Several prediction models for pancreatic cancer have been developed in populations with new-onset diabetes or a family history of pancreatic cancer; however, these models require further validation. Despite recent progress in pancreatic cancer screening, the quantity and quality of related studies are also unsatisfactory, especially with respect to the identification of high-risk populations and development of effective screening modality. Apart from the populations with familial genetic risk and those at a high risk of sporadic pancreatic cancer, risk factors such as new-onset diabetes may be a new direction for timely intervention. We hope this work will provide new ideas for further prevention and treatment of pancreatic cancer. •Both incidence and mortality rate of pancreatic cancer has increased in recent years.•Risk factors for PDAC include individual characteristics, lifestyle and environment, and disease status.•The current established modality for effective early detection of PDAC is lacking.•Development of effective biomarkers predicting the prognosis are in high demand.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>34216688</pmid><doi>10.1016/j.canlet.2021.06.027</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-2691-0411</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 2021-11, Vol.520, p.1-11
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_2548403274
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Biomarker
Cancer screening
Diabetes mellitus
Early Detection of Cancer
Epidemiology
Gender differences
Humans
Literature reviews
Malignancy
Mathematical models
Medical prognosis
Mortality
Mutation
Pancreas - pathology
Pancreatic cancer
Pancreatic Neoplasms - diagnosis
Pancreatic Neoplasms - epidemiology
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - therapy
Population genetics
Prediction model
Prediction models
Prognosis
Risk Factors
Screening
Systematic review
Trend
title Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T21%3A24%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20the%20epidemiology%20of%20pancreatic%20cancer:%20Trends,%20risk%20factors,%20screening,%20and%20prognosis&rft.jtitle=Cancer%20letters&rft.au=Cai,%20Jie&rft.date=2021-11-01&rft.volume=520&rft.spage=1&rft.epage=11&rft.pages=1-11&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2021.06.027&rft_dat=%3Cproquest_cross%3E2570438080%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2570438080&rft_id=info:pmid/34216688&rft_els_id=S0304383521003128&rfr_iscdi=true